S. Brettschneider

Decreased serum amyloid β1–42 autoantibody levels in Alzheimer’s disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid β1–42 peptide

H. Möller, H. Hampel, S. Teipel, 2005, Biological Psychiatry.

Diagnostic Value of PCR for Detection of Borrelia burgdorferi in Skin Biopsy and Urine Samples from Patients with Skin Borreliosis

N. Klugbauer, H. Hofmann, H. Bruckbauer, 1998, Journal of Clinical Microbiology.

Seroprevalence of bovine ephemeral fever virus in domesticated and wildlife species during epidemic and inter-epidemic periods (2000-2009) in Israel.

E. Klement, B. Gelman, O. Aziz-Boaron, 2015, Transboundary and emerging diseases.

Core biological marker candidates of Alzheimer’s disease – perspectives for diagnosis, prediction of outcome and reflection of biological activity

H. Möller, K. Blennow, H. Hampel, 2004, Journal of Neural Transmission.

Intravenous immunoglobulins containing antibodies against β-amyloid for the treatment of Alzheimer’s disease

H. Möller, W. Oertel, A. Spottke, 2004, Journal of Neurology, Neurosurgery & Psychiatry.